Dsc Advisors, L.P. Biomarin Pharmaceutical Inc Put Options Transaction History

Dsc Advisors, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $2.17 Million - $2.51 Million	25,000 New	25,000 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.29 Million - $3.88 Million	40,000 New	40,000 $3.39 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2.51 Million - $3.2 Million	35,000 New	35,000 $3.09 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.